“This positive evolution was mainly due to the significant recovery of the weight control business, whose sales increased 18.1% [on Q1 2012],” the company said.
Its broader healthy supplements range also performed well, the company said. Weight loss supplements accounted for 62% of the company’s yearly sales; healthy supplements 27% but growing at 30.4% in Q1. Beauty supplements represented 7.4% of sales but were flat.
Overall turnover for the current quarter was €10.74m – up 13.4% over Q1 2012.
Flagship weight control products Turbodraine and CaloriLight grew 5.9% and 23.3%, respectively, with new product – Turboslim – contributing €1.37m in the three months.
The company noted of its health range: “On the other hand, the good performance of the health range was backed by the positive evolution of the new product launches that were presented to the market last fall -Gélée Royale, DéfensActiv' and Chondralgic – as well as on the maintenance of sales of one of its flagship products, Vitalité 4G.”
France, Spain, Benelux and the UK are the company’s strongest markets.
Forté Pharma had sales of €29.93m in 2012 but said sales were often higher in Q1 due to seasonal buying patterns.